Matthew Christopher

Medicine & Life Sciences

1. Granulocyte Colony-Stimulating Factor 100%
2. Hematopoietic Stem Cells 88%
3. Osteoblasts 72%
4. Acute Myeloid Leukemia 54%
5. Bone Marrow 52%
6. Hematopoietic Stem Cell Mobilization 41%
7. Granulocyte Colony-Stimulating Factor Receptors 38%
8. Mutation 33%
9. Chemokine CXCL12 27%
10. Leukemia 27%
11. Myeloid Cells 26%
12. Recurrence 25%
13. Transplantation 24%
14. Genome 22%
15. Cytogenetic Analysis 21%
16. Critical Pathways 21%
17. Homologous Transplantation 20%
18. Myelodysplastic Syndromes 20%
19. Toll-Like Receptors 20%
20. Precursor Cell Lymphoblastic Leukemia-Lymphoma 18%
21. Neutrophils 17%
22. Stromal Cells 16%
23. Methylation 16%
24. Whole Genome Sequencing 16%
25. Maintenance 15%
26. Prostate 15%
27. Cytokines 14%
28. Homeostasis 13%
29. MHC Class II Genes 13%
30. Carcinoma 12%
31. Exome 11%
32. Apoptosis 11%
33. flt3 ligand protein 11%
34. Therapeutics 10%
35. Heterografts 10%
36. Bone Marrow Cells 10%
37. Neoplasms 10%
38. Messenger RNA 10%
39. Integrin alpha4beta1 10%
40. Transgenic Mice 9%
41. Stem Cell Factor 8%
42. Transplants 8%
43. Unrelated Donors 8%
44. Gene Frequency 7%
45. Down-Regulation 7%
46. Progression-Free Survival 7%
47. Stem Cell Transplantation 6%
48. Hematopoietic Stem Cell Transplantation 6%
49. Cytosine 6%
50. Peptide Hydrolases 6%